Generic placeholder image

Mini-Reviews in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

Review Article

An Overview of Treatment Guidelines and Methods of Synthesis of Drugs Used in Leprosy Chemotherapy

Author(s): Luiz C.S. Pinheiro*, Julio C. Borges, Vinicius R. Campos and Leonardo C. Dantas

Volume 23, Issue 4, 2023

Published on: 23 September, 2022

Page: [497 - 512] Pages: 16

DOI: 10.2174/1389557522666220415233627

Abstract

Leprosy is a Neglected Tropical Disease (NTDs) caused by Mycobacterium leprae (M. leprae). The treatment is considered effective, however, the high dose Multidrug Therapy (MDT) for a long period and its adverse effects result in the abandonment of the treatment by patients. Indeed, antimicrobial resistance is still an obstacle that must be overcome in the treatment of leprosy. In the present article, we reviewed the WHO guidelines for the chemotherapy of leprosy and the methods of synthesis of these drugs.

Keywords: Leprosy, rifampicin, clofazimine, dapsone, clarithromycin, minocycline, ofloxacin.

« Previous
[1]
World Health Organization (WHO). Available from: https://www.who.int/news-room/fact-sheets/detail/leprosy (Accessed on: September 08, 2021).
[2]
Irgens, L.M. The discovery of the leprosy bacillus. Tidsskr. Nor. Laegeforen., 2002, 122(7), 708-709.
[PMID: 11998735]
[3]
Bechler, R.G. Hansen versus Neisser: Scientific controversies over the ‘discovery’ of the bacillus of leprosy. Hist. Cienc. Saude Manguinhos, 2012, 19(3), 815-842.
[http://dx.doi.org/10.1590/S0104-59702012000300003] [PMID: 23070374]
[4]
International Leprosy Association. Available from: https://leprosyhistory.org/database/person1 (Accessed on: September 09, 2021).
[5]
World health organization (WHO). Regional office for south-east asia. ( 2018) . Guidelines for the diagnosis, treatment and prevention of leprosy. World health organization. Regional office for southeast asia. 2018. Available from: https://apps.who.int/iris/handle/10665/274127 (Accessed on: September 09, 2021).
[6]
Acebrón-García-de-Eulate, M.; Blundell, T.L.; Vedithi, S.C. Strategies for drug target identification in Mycobacterium leprae. Drug Discov. Today, 2021, 26(7), 1569-1573.
[http://dx.doi.org/10.1016/j.drudis.2021.03.026] [PMID: 33798649]
[7]
Ploemacher, T.; Faber, W.R.; Menke, H.; Rutten, V.; Pieters, T. Reservoirs and transmission routes of leprosy; A systematic review. PLoS Negl. Trop. Dis., 2020, 14(4), e0008276.
[http://dx.doi.org/10.1371/journal.pntd.0008276] [PMID: 32339201]
[8]
Alemu Belachew, W.; Naafs, B. Position statement: LEPROSY: Diagnosis, treatment and follow-up. J. Eur. Acad. Dermatol. Venereol., 2019, 33(7), 1205-1213.
[http://dx.doi.org/10.1111/jdv.15569] [PMID: 30945360]
[9]
Mungroo, M.R.; Khan, N.A.; Siddiqui, R. Mycobacterium leprae: Pathogenesis, diagnosis, and treatment options. Microb. Pathog., 2020, 149, 104475.
[http://dx.doi.org/10.1016/j.micpath.2020.104475] [PMID: 32931893]
[10]
Thakur, S.; Chauhan, V. State of the globe: “Hansen’s disease – Down but not out in the SARS-CoV-2 era. J. Glob. Infect. Dis., 2020, 12(4), 165-166.
[http://dx.doi.org/10.4103/jgid.jgid_396_20] [PMID: 33888954]
[11]
World Health Organization (WHO). Regional Office for SouthEast Asia, Global Leprosy Programme. Global Leprosy Strategy 2016–2020: Accelerating towards a leprosy-free world. New Delhi: WHO Regional Office for South-East Asia. 2016. Available from: http://apps.who.int/iris/bitstream/handle/10665/208824/9789290225096_en.pdf (Accessed on: September 08, 2021).
[12]
Ahmed, M.M.H. Anuradha; Wadhwa, P. A review on agents for the treatment of leprosy infection. Asian J. Pharm. Clin. Res., 2021, 14(3), 25-29.
[http://dx.doi.org/10.22159/ajpcr.2021.v14i3.40373]
[13]
Blok, D.J.; de Vlas, S.J.; Geluk, A.; Richardus, J.H. Minimum requirements and optimal testing strategies of a diagnostic test for leprosy as a tool towards zero transmission: A modeling study. PLoS Negl. Trop. Dis., 2018, 12(5), e0006529.
[http://dx.doi.org/10.1371/journal.pntd.0006529] [PMID: 29799844]
[14]
Gaschignard, J.; Grant, A.V.; Thuc, N.V.; Orlova, M.; Cobat, A.; Huong, N.T.; Ba, N.N.; Thai, V.H.; Abel, L.; Schurr, E.; Alcaïs, A. Pauci-and multibacillary leprosy: Two Distinct, genetically neglected diseases. PLoS Negl. Trop. Dis., 2016, 10(5), e0004345.
[http://dx.doi.org/10.1371/journal.pntd.0004345] [PMID: 27219008]
[15]
Adams, L.B. Susceptibility and resistance in leprosy: Studies in the mouse model. Immunol. Rev., 2021, 301(1), 157-174.
[http://dx.doi.org/10.1111/imr.12960] [PMID: 33660297]
[16]
World Health Organization (WHO). Global leprosy (Hansen disease) update, 2019: time to step-up prevention initiatives. 2019, 95, 4417-4440. Available from: https://www.who.int/publications/i/item/who-wer9536 (Accessed on: September 09, 2021).
[17]
World Health Organization (WHO). World Health Assembly, Elimination of leprosy: resolution of the 44th resolution 44.9 1991. Available from: https://www.who.int/neglected_diseases/mediacentre/WHA_44.9_Eng.pdf (Accessed on: September 08, 2021).
[18]
Lockwood, D.N.J.; Suneetha, S. Leprosy: too complex a disease for a simple elimination paradigma., Available from: https://www.who.int/bulletin/volumes/83/3/230.pdf (Accessed on: September 08, 2021).
[19]
Cambau, E.; Saunderson, P.; Matsuoka, M.; Cole, S.T.; Kai, M.; Suffys, P.; Rosa, P.S.; Williams, D.; Gupta, U.D.; Lavania, M.; Cardona-Castro, N.; Miyamoto, Y.; Hagge, D.; Srikantam, A.; Hongseng, W.; Indropo, A.; Vissa, V.; Johnson, R.C.; Cauchoix, B.; Pannikar, V.K.; Cooreman, E.A.W.D.; Pemmaraju, V.R.R.; Gillini, L. WHO surveillance network of antimicrobial resistance in leprosy. Antimicrobial resistance in leprosy: Results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-15. Clin. Microbiol. Infect., 2018, 24(12), 1305-1310.
[http://dx.doi.org/10.1016/j.cmi.2018.02.022] [PMID: 29496597]
[20]
Considerations for implementing mass treatment, active case‐ finding and population-based surveys for neglected tropical diseases in the context of the COVID-19 pandemic: Interim guidance. 2020. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-neglected-tropical-diseases-2020-1 (Accessed on: September 14, 2021).
[21]
World Health Organization (WHO) . WHO Expert Committee on leprosy: eighth report. World Health Organization (2012) 2012. Available from: https://apps.who.int/iris/handle/10665/75151 (Accessed on: September 15, 2021).
[22]
Gillini, L.; Cooreman, E.; Wood, T.; Pemmaraju, V.R.; Saunderson, P. Global practices in regard to implementation of preventive measures for leprosy. PLoS Negl. Trop. Dis., 2017, 11(5), e0005399.
[http://dx.doi.org/10.1371/journal.pntd.0005399] [PMID: 28472183]
[23]
Parajuli, N.; Poudyal, Y. Leprosy postexposure prophylaxis with single-dose rifampicin: Nepalese dermatologist’s dilemma. PLoS Negl. Trop. Dis., 2021, 15(4), e0009039.
[http://dx.doi.org/10.1371/journal.pntd.0009039] [PMID: 33830989]
[24]
Chen, X.; He, J.; Liu, J.; You, Y.; Yuan, L.; Wen, Y. Nested PCR and the TaqMan SNP Genotyping Assay enhanced the sensitivity of drug resistance testing of Mycobacterium leprae using clinical specimens of leprosy patients. PLoS Negl. Trop. Dis., 2019, 13(12), e0007946.
[http://dx.doi.org/10.1371/journal.pntd.0007946] [PMID: 31881061]
[25]
van Brakel, W.H.; Nicholls, P.G.; Wilder-Smith, E.P.; Das, L.; Barkataki, P.; Lockwood, D.N.J. INFIR Study Group. Early diagnosis of neuropathy in leprosy-comparing diagnostic tests in a large prospective study (the INFIR cohort study). PLoS Negl. Trop. Dis., 2008, 2(4), e212.
[http://dx.doi.org/10.1371/journal.pntd.0000212] [PMID: 18382604]
[26]
Lockwood, D.N.J.; Lambert, S.; Srikantam, A.; Darlong, J.; Pai, V.V.; Butlin, C.R.; de Barros, B.; Negera, E.; Walker, S.L. Three drugs are unnecessary for treating paucibacillary leprosy-A critique of the WHO guidelines. PLoS Negl. Trop. Dis., 2019, 13(10), e0007671.
[http://dx.doi.org/10.1371/journal.pntd.0007671] [PMID: 31671087]
[27]
Smith, C.S.; Aerts, A.; Saunderson, P.; Kawuma, J.; Kita, E.; Virmond, M. Multidrug therapy for leprosy: A game changer on the path to elimination. Lancet Infect. Dis., 2017, 17(9), e293-e297.
[http://dx.doi.org/10.1016/S1473-3099(17)30418-8] [PMID: 28693853]
[28]
National Leprosy Eradication Programme I. Guidelines for Post Exposure Prophylaxis 2016.. 2016. Available from: http://nlep.nic.in/pdf/OG_PEP_F.pdf (Accessed on: 10 August 2021).
[29]
Towards zero leprosy. Global leprosy ( Hansen’s Disease) strategy 2021-2030. Available from: http://www.who.int/publications/i/item/9789290228509 (Accessed on: September 16, 2021).
[30]
Ending the neglect to attain the Sustainable Development Goals: A road map for neglected tropical diseases 2021-2030. Geneva: World Health Organization, 2020. Licence: CC BY-NC-SA 3.0 IGO. 2020. Available from: https://www.who.int/publications/i/item/9789240010352 (Accessed on: September 14, 2021).
[31]
Lockwood, D.N.J.; Krishnamurthy, P.; Kumar, B.; Penna, G. Single-dose rifampicin chemoprophylaxis protects those who need it least and is not a cost-effective intervention. PLoS Negl. Trop. Dis., 2018, 12(6), e0006403.
[http://dx.doi.org/10.1371/journal.pntd.0006403] [PMID: 29879118]
[32]
Beltrán-Alzate, C.; López Díaz, F.; Romero-Montoya, M.; Sakamuri, R.; Li, W.; Kimura, M.; Brennan, P.; Cardona-Castro, N. Leprosy drug resistance surveillance in Colombia: The experience of a sentinel country. PLoS Negl. Trop. Dis., 2016, 10(10), e0005041.
[http://dx.doi.org/10.1371/journal.pntd.0005041] [PMID: 27706165]
[33]
da Silva Rocha, A.; Cunha, Md.; Diniz, L.M.; Salgado, C.; Aires, M.A.P.; Nery, J.A.; Gallo, E.N.; Miranda, A.; Magnanini, M.M.; Matsuoka, M.; Sarno, E.N.; Suffys, P.N.; de Oliveira, M.L. Drug and multidrug resistance among Mycobacterium leprae isolates from Brazilian relapsed leprosy patients. J. Clin. Microbiol., 2012, 50(6), 1912-1917.
[http://dx.doi.org/10.1128/JCM.06561-11] [PMID: 22495562]
[34]
Yu, M.; Wu, K.; Pei, B.; Yang, D.; Wang, Q.; Wang, H.; Shen, J.; Yan, L.; Zhang, G. Rifampicin-resistant Mycobacterium leprae in an elderly leprosy patient in the people’s Republic of China. Clin. Interv. Aging, 2013, 8, 1097-1099.
[http://dx.doi.org/10.2147/CIA.S49653] [PMID: 23986632]
[35]
Yokoyama, K.; Kim, H.; Mukai, T.; Matsuoka, M.; Nakajima, C.; Suzuki, Y. Impact of amino acid substitutions in B subunit of DNA gyrase in Mycobacterium leprae on fluoroquinolone resistance. PLoS Negl. Trop. Dis., 2012, 6(10), e1838.
[http://dx.doi.org/10.1371/journal.pntd.0001838] [PMID: 23071850]
[36]
Andrade, E.S.N.; Brandão, J.G.; da Silva, J.S.; Kurizky, P.S.; Rosa, P.S.; de Araújo, W.N.; Gomes, C.M. A systematic review and meta-analysis of studies on the diagnostic accuracy and screening of tests to detect antimicrobial resistance in leprosy. Diagn. Microbiol. Infect. Dis., 2021, 100(1), 115325.
[http://dx.doi.org/10.1016/j.diagmicrobio.2021.115325] [PMID: 33556650]
[37]
Chaves, L.L.; Patriota, Y.; Soares-Sobrinho, J.L.; Vieira, A.C.C.; Lima, S.A.C.; Reis, S. Drug delivery systems on leprosy therapy: Moving towards eradication? Pharmaceutics, 2020, 12(12), 1202.
[http://dx.doi.org/10.3390/pharmaceutics12121202] [PMID: 33322356]
[38]
Ministry of health. Health surveillance department. Department of communicable disease surveillance. Practical guide on leprosy. 2017. Available from: https://portalarquivos2.saude.gov.br/images/pdf/2017/novembro/22/Guia-Pratico-de-Hanseniase-WEB.pdf (Accessed on: September 14, 2021).
[39]
Souza, C.D.F.; Paiva, J.P.S.; Leal, T.C.; Urashima, G.D.S. Leprosy in Brazil in the 21st century: analysis of epidemiological and operational indicators using inflection point regression. An. Bras. Dermatol., 2020, 95(6), 743-747.
[http://dx.doi.org/10.1016/j.abd.2019.09.031] [PMID: 33010990]
[40]
Bera, S.; Mondal, D. Insights of synthetic analogues of anti-leprosy agents. Bioorg. Med. Chem., 2019, 27(13), 2689-2717.
[http://dx.doi.org/10.1016/j.bmc.2019.04.032] [PMID: 31103404]
[41]
Floss, H.G.; Yu, T.W. Rifamycin-mode of action, resistance, and biosynthesis. Chem. Rev., 2005, 105(2), 621-632.
[http://dx.doi.org/10.1021/cr030112j] [PMID: 15700959]
[42]
Fischer, M. Leprosy - an overview of clinical features, diagnosis, and treatment. J. Dtsch. Dermatol. Ges., 2017, 15(8), 801-827.
[http://dx.doi.org/10.1111/ddg.13301] [PMID: 28763601]
[43]
Shouli, X.; Li, X.; Mingshan, D.; Jian, H.; Xueqing, D.; Lingxiang, S. One-pot processing method for synthesizing rifampicin. C.N. Patent 1690059A, November 02, 2005.
[44]
Guangwen, C.; Zhenghui, W.; Mei, H. Method for continuously preparing benzoxazine rifamycin. C.N. Patent 110684037A, January 14, 2020.
[45]
Maggi, N.; Sensi, P. Mannich bases of rifamycin SV. U.S. Patent 3349082A, October 24, 1967.
[46]
Maggi, N.; Sensi, P. Derivatives of rifamycin SV. U.S. Patent 3342810A, September 19, 1967.
[47]
Bruzzesse, T. Process for the preparation of rifampicin. U.S. Patent 4174320A, November 13, 1979.
[48]
Li, X.; Liu, Z.; Qi, H.; Fang, Z.; Huang, S.; Miao, S.; Guo, K. Continuous preparation for rifampicin. J. Flow Chem., 2018, 8, 129-138.
[http://dx.doi.org/10.1007/s41981-018-0017-2]
[49]
Cruz, R.C.D.S.; Bührer-Sékula, S.; Penna, M.L.F.; Penna, G.O.; Talhari, S. Leprosy: Current situation, clinical and laboratory aspects, treatment history and perspective of the uniform multidrug therapy for all patients. An. Bras. Dermatol., 2017, 92(6), 761-773.
[http://dx.doi.org/10.1590/abd1806-4841.20176724] [PMID: 29364430]
[50]
Barr, J. A short history of dapsone, or an alternative model of drug development. J. Hist. Med. Allied Sci., 2011, 66(4), 425-467.
[http://dx.doi.org/10.1093/jhmas/jrq068] [PMID: 20966036]
[51]
Wolf, R.; Matz, H.; Orion, E.; Tuzun, B.; Tuzun, Y. Dapsone. Dermatol. Online J., 2002, 8(1), 2.
[http://dx.doi.org/10.5070/D330M4B5KR] [PMID: 12165212]
[52]
Allegrini, P.; Mantegazza, S. Process for the preparation of sulfonamide compounds. U.S. Patent 2014303402A1, October 09, 2014.
[53]
Buckles, R.E. A synthesis of bis(p-aminophenyl)sulfone for laboratory classes. J. Chem. Educ., 1954, 31(1), 36-37.
[http://dx.doi.org/10.1021/ed031p36]
[54]
Yang, Y.; Chen, Z.; Rao, Y. The synthesis of diarylsulfones with simple arenes and K2S2O8 through double C-S bond formation. Chem. Commun. (Camb.), 2014, 50(95), 15037-15040.
[http://dx.doi.org/10.1039/C4CC05964F] [PMID: 25327213]
[55]
Gopal, M.; Padayatchi, N.; Metcalfe, J.Z.; O’Donnell, M.R. Systematic review of clofazimine for the treatment of drug-resistant tuberculosis. Int. J. Tuberc. Lung Dis., 2013, 17(8), 1001-1007.
[http://dx.doi.org/10.5588/ijtld.12.0144] [PMID: 23541151]
[56]
Chauhan, S.M.S.; Singh, R. Geetanjali. An Improved Synthesis of N-Substituted-2-nitroanilines. Synth. Commun., 2003, 33(16), 2899-2906.
[http://dx.doi.org/10.1081/SCC-120022180]
[57]
Loos, P.; Alex, H.; Hassfeld, J.; Lovis, K.; Platzek, J.; Steinfeldt, N.; Huebner, S. Selective hydrogenation of halogenated nitroaromatics to haloanilines in batch and flow. Org. Process Res. Dev., 2016, 20(2), 452-464.
[http://dx.doi.org/10.1021/acs.oprd.5b00170]
[58]
Bing, Y. Method for synthesizing key clofazimine intermediate N- (4-chlorphenyl)-1,2-phenylenediamine. W.O. Patent 2019037161A1, February 28, 2019.
[59]
Barry, V.C.; Dublin, R.; Belton, J.G.; Conalty, M.L.; O’sullivan, J.F.; Ernst, H. New phenazine derivatives. U.S. Patent 2948726A, August 06, 1960.
[60]
O’Sullivan, J.F.; Conalty, M.L.; Morrison, N.E. Clofazimine analogues active against a clofazimine-resistant organism. J. Med. Chem., 1988, 31(3), 567-572.
[http://dx.doi.org/10.1021/jm00398a013] [PMID: 3279207]
[61]
Xiaoying, L.; Junzheng, H.; Xiaowen, G.; Luning, H.; Hong, G. Preparation method for clofazimine intermediate. C.N. Patent 106916069A, July 04, 2017.
[62]
Woo, S.H.; Park, G.; Chang, S.; Lim, G. Intermediate for producing phenazine derivative, and method for producing same. W.O. Patent 2020166984A1, August 20, 2020.
[63]
Hassounah, I.A.; Shehata, N.A.; Kimsawatde, G.C.; Hudson, A.G.; Sriranganathan, N.; Joseph, E.G.; Mahajan, R.L. Designing and testing single tablet for tuberculosis treatment through electrospinning.Fabrication and Self-Assembly of Nanobiomaterials. Applications of Nanobiomaterials; Grumezescu, A.M., Ed.; William Andrew Publishing: Norwich, NY, 2016, pp. 335-365.
[http://dx.doi.org/10.1016/B978-0-323-41533-0.00011-8]
[64]
Sturgill, M.G.; Rapp, R.P. Clarithromycin: Review of a new macrolide antibiotic with improved microbiologic spectrum and favorable pharmacokinetic and adverse effect profiles. Ann. Pharmacother., 1992, 26(9), 1099-1108.
[http://dx.doi.org/10.1177/106002809202600912] [PMID: 1421677]
[65]
Neu, H.C. The development of macrolides: Clarithromycin in perspective. J. Antimicrob. Chemother., 1991, 27(Suppl. A), 1-9.
[http://dx.doi.org/10.1093/jac/27.suppl_A.1] [PMID: 1827094]
[66]
Vardanyan, R.S.; Hruby, V.J. Synthesis of Essential Drugs. In: Antibiotics, 1st ed; Vardanyan, R.S.; Hruby, V.J., Eds.; Elsevier Science: Amsterdam, Netherlands, 2006; pp. 425-498.
[http://dx.doi.org/10.1016/B978-044452166-8/50032-7]
[67]
Morimoto, S.; Takahashi, Y.; Watanabe, Y.; Omura, S. Chemical modification of erythromycins. I. Synthesis and antibacterial activity of 6-O-methylerythromycins A. J. Antibiot. (Tokyo), 1984, 37(2), 187-189.
[http://dx.doi.org/10.7164/antibiotics.37.187] [PMID: 6706855]
[68]
Yang, C.; Patel, H.H.; Ku, Y.; Liu, J. 2'-Protected 3'- dimethylamine, 9-etheroxime erythromycin A derivatives. U.S. Patent 5719272A, February 17, 1998.
[69]
Gasc, J.C.; d’Ambrieres, S.G.; Lutz, A.; Chantot, J.F. New ether oxime derivatives of erythromycin A. A structure-activity relationship study. J. Antibiot. (Tokyo), 1991, 44(3), 313-330.
[http://dx.doi.org/10.7164/antibiotics.44.313] [PMID: 1827435]
[70]
Rao, X.; Ding, Z.; Lou, H.; Wu, J.; Fang, Y.; Deng, B.; Baineng, D. Method of preparing clarithromycin. U.S. Patent 8288514B2, October 16, 2012.
[71]
Brogden, R.N.; Speight, T.M.; Avery, G.S. Minocycline: A review of its antibacterial and pharmacokinetic properties and therapeutic use. Drugs, 1975, 9(4), 251-291.
[http://dx.doi.org/10.2165/00003495-197509040-00005] [PMID: 1173232]
[72]
Garrido-Mesa, N.; Zarzuelo, A.; Gálvez, J. Minocycline: Far beyond an antibiotic. Br. J. Pharmacol., 2013, 169(2), 337-352.
[http://dx.doi.org/10.1111/bph.12139] [PMID: 23441623]
[73]
Nettis, M.A. Minocycline in major depressive disorder: And overview with considerations on treatment-resistance and comparisons with other psychiatric disorders. Brain Behav. Immun. Health, 2021, 17, 100335.
[http://dx.doi.org/10.1016/j.bbih.2021.100335] [PMID: 34568852]
[74]
Martins, A.M.; Marto, J.M.; Johnson, J.L.; Graber, E.M. A review of systemic minocycline side effects and topical minocycline as a safer alternative for treating acne and rosacea. Antibiotics (Basel), 2021, 10(7), 757.
[http://dx.doi.org/10.3390/antibiotics10070757] [PMID: 34206485]
[75]
Saito, Y.; Kasai, M. Process for producing 7-amino-6-demethyl-6- deoxytetracycline. U.S. Patent 4849136A, July 18, 1989.
[76]
Gu, K.; Wang, X. Preparation method of minocycline. C.N. Patent 111892509A, November 16, 2020.
[77]
Chen, J.; Ren, Y.; Chen, Y. Method for synthesizing minocycline hydrochloride. C.N. Patent 112574057A, March 30, 2021.
[78]
Rubinstein, E. History of quinolones and their side effects. Chemotherapy, 2001, 47(3)(Suppl. 3), 3-8.
[http://dx.doi.org/10.1159/000057838] [PMID: 11549783]
[79]
Paris, J-M. 1.3 Chirality in antibacterial agents. In: Comprehensive Chirality; Carreira, E.M.; Yamamoto, H., Eds.; Elsevier: Amsterdam, Netherlands, 2012; pp. 30-53.
[http://dx.doi.org/10.1016/B978-0-08-095167-6.00109-9]
[80]
Appelbaum, P.C.; Hunter, P.A. The fluoroquinolone antibacterials: Past, present and future perspectives. Int. J. Antimicrob. Agents, 2000, 16(1), 5-15.
[http://dx.doi.org/10.1016/S0924-8579(00)00192-8] [PMID: 11185413]
[81]
Pham, T.D.M.; Ziora, Z.M.; Blaskovich, M.A.T. Quinolone antibiotics. MedChemComm, 2019, 10(10), 1719-1739.
[http://dx.doi.org/10.1039/C9MD00120D] [PMID: 31803393]
[82]
Hayakawa, I.; Hiramitsu, T.; Tanaka, Y. Benzoxazine derivatives U.S. Patent 4382892A, May 10, 1983.
[83]
Wu, Z.; Yu, Y.; Yu, W. One-step synthesis method for levofloxacin and ofloxacin. W.O. Patent 2013189117A1, December 27, 2013.
[84]
Mitscher, L.A.; Chu, D.T. Process for preparation of racemate and optically active ofloxacin and related derivatives. U.S. Patent 4777253A, October 11, 1988.
[85]
Yang, H.; Mao, J.; Sun, X. Preparation method of novel ofloxacin intermediate. C.N. Patent 104402917A, March 11, 2015.
[86]
Yang, Z.; Yang, Q.; Chen, Q.; Wang, Y.; Wang, Z.; Zhang, W.; Han, D.; Wu, G.; Wang, J.; Jiao, G. Preparation method of ofloxacin. C.N. Patent 103360410A, October 23, 2013.
[87]
Lyu, X.; Zhang, T.; Zhou, S. Synthesizing method of ofloxacin and levofloxacin. C.N. Patent 108892676A, November 27, 2018.
[88]
Ye, W.; Zhang, W.; Yang, Z. Methods for preparation of levofloxacin and ofloxacin. W.O. Patent 2005123746A1, December 29, 2005.

© 2025 Bentham Science Publishers | Privacy Policy
Request history8.2.27PHP Version311msRequest Duration28MBMemory UsageGET article/{article_id}/{param?}Route
  • warninglog[15:30:41] LOG.warning: Optional parameter $article_id declared before required parameter $request i...
  • warninglog[15:30:41] LOG.warning: Function strftime() is deprecated in /home/alphaeurekaselec/public_html/stor...
  • warninglog[15:30:41] LOG.warning: trim(): Passing null to parameter #1 ($string) of type string is deprecated ...
  • warninglog[15:30:41] LOG.warning: trim(): Passing null to parameter #1 ($string) of type string is deprecated ...
  • warninglog[15:30:41] LOG.warning: Function strftime() is deprecated in /home/alphaeurekaselec/public_html/stor...
  • Booting (112ms)time
  • Application (199ms)time
  • 1 x Application (63.92%)
    199ms
    1 x Booting (36.08%)
    112ms
    14 templates were rendered
    • articlearticle.blade.php#?blade
    • includes.article_top_bannerarticle_top_banner.blade.php#?blade
    • includes.article_referencearticle_reference.blade.php#?blade
    • export_citation_formexport_citation_form.blade.php#?blade
    • includes.article_bottom_bannerarticle_bottom_banner.blade.php#?blade
    • includes.inc_related_journalsinc_related_journals.blade.php#?blade
    • includes.inc_related_ebooksinc_related_ebooks.blade.php#?blade
    • includes.journal_rightmenujournal_rightmenu.blade.php#?blade
    • includes.journal_right_bannerjournal_right_banner.blade.php#?blade
    • layouts.appapp.blade.php#?blade
    • layouts._login_access_login_access.blade.php#?blade
    • layouts._header_header.blade.php#?blade
    • layouts._main_menu_main_menu.blade.php#?blade
    • layouts._footer_menu_footer_menu.blade.php#?blade
    uri
    GET article/{article_id}/{param?}
    middleware
    web, check_user_access
    controller
    App\Http\Controllers\ArticleController@GetArticleDetails
    namespace
    App\Http\Controllers
    where
    as
    article
    file
    app/Http/Controllers/ArticleController.php:1974-2510
    31 statements were executed, 4 of which were duplicates, 27 unique. Show only duplicated119ms
    • Connection Establishedalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 9. middleware::check_user_access:24
      • 10. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 11. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address (ip_address,visitor_agent,visitor_count, created_on,updated_on) VALUES ('316587137','',1,1740497441,1740497441) ON DUPLICATE KEY UPDATE visitor_count=visitor_count + 1, updated_on=1740497441
      1.08msalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 11. middleware::check_user_access:24
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address_detail (ip_address,visitor_url,visitor_count, created_on,updated_on) VALUES ('316587137','/article/122615',1,1740497441,1740497441)
      680μsalphaeurekaselec_live_10_06_2022UserAccessCheck.php#27
      Backtrace
      • 11. middleware::check_user_access:27
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_trail WHERE to_ip >= 316587137 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316587137) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_corporate WHERE to_ip >= 316587137 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316587137) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_token WHERE to_ip >= 316587137 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316587137) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_trail WHERE to_ip >= 316587137 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316587137) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_corporate WHERE to_ip >= 316587137 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316587137) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_token WHERE to_ip >= 316587137 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316587137) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_trail WHERE to_ip >= 316587137 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316587137) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_corporate WHERE to_ip >= 316587137 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316587137) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_token WHERE to_ip >= 316587137 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316587137) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_trail WHERE to_ip >= 316587137 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316587137) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_corporate WHERE to_ip >= 316587137 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316587137) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_token WHERE to_ip >= 316587137 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316587137) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_trail WHERE to_ip >= 316587137 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316587137) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_corporate WHERE to_ip >= 316587137 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316587137) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_token WHERE to_ip >= 316587137 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316587137) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_disease_corporate WHERE to_ip >= 316587137 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 316587137) limit 1
      11.42msalphaeurekaselec_live_10_06_2022UserAccess.php#784
      Bindings
      • 0: 316587137
      • 1: 316587137
      • 2: 316587137
      • 3: 316587137
      • 4: 316587137
      • 5: 316587137
      • 6: 316587137
      • 7: 316587137
      • 8: 316587137
      • 9: 316587137
      • 10: 316587137
      • 11: 316587137
      • 12: 316587137
      • 13: 316587137
      • 14: 316587137
      • 15: 316587137
      Backtrace
      • 14. app/Models/UserAccess/UserAccess.php:784
      • 15. middleware::check_user_access:114
      • 16. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 18. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
    • SELECT at.type_name, p.copyright, p.publisher_location,m.month,y.year, a.publish_on, a.nid article_nid,a.article_id, a.pmid, a.issue_id, a.title, a.abstract,a.podcast,a.altmetric_score,a.altmetric_url,a.kudos_url, a.page_count, a.first_page, a.elocator, a.last_page, i.publication_date, a.file_name, a.file_path, a.doi, a.is_epub,a.epub_type, a.volume_id, a.is_uploaded, a.editor_choice, a.is_epub, j.image_file_name, a.article_no, a.art_type AS article_type, a.supplementary_filename,a.html_filename,a.prc_filename,a.epub_filename, a.graph_abs_lg_filename, a.graph_abs_sm_filename, a.oa_image_lg_filename, a.oa_image_sm_filename, j.journal_banner,a.animated_abstract,a.erratum_in,a.erratum_for, (CASE WHEN a.issue_id =0 THEN j.epub_price ELSE j.price END) AS sell_price, j.epub_price, j.nid AS jour_nid, j.title AS journal_title, j.issn, j.eissn,j.journal_id, j.subtitle AS jour_subtitle, v.volume_id,v.volume_name AS volume, v.year_id, i.title AS issue, i.month_id ,i.type issue_type, j.subtitle,j.formerly_title, ac.subtitle AS epub_title,a.crossmark_enabled,a.text_mining_urls,a.license_urls,a.created, a.receivedate, a.revisedate, a.acceptdate,js.js_title FROM article a LEFT JOIN article_section ac ON a.is_epub = ac.art_sec_id LEFT JOIN journal_section js ON a.js_id = js.js_id LEFT JOIN article_type at ON a.art_type = at.art_type_id LEFT JOIN issue i ON a.issue_id = i.issue_id LEFT JOIN month m ON m.id = i.month_id LEFT JOIN volume v ON v.volume_id = a.volume_id INNER JOIN year y ON y.id = v.year_id INNER JOIN journal j ON j.journal_id = a.journal_id INNER JOIN publisher p ON p.publisher_id = j.publisher_id WHERE a.article_id=122615
      750μsalphaeurekaselec_live_10_06_2022Article.php#408
      Backtrace
      • 11. app/Models/Article.php:408
      • 12. app/Http/Controllers/ArticleController.php:2515
      • 13. app/Http/Controllers/ArticleController.php:2035
      • 14. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 15. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `journal` where `journal_id` = 56 limit 1
      830μsalphaeurekaselec_live_10_06_2022Journal.php#64
      Bindings
      • 0: 56
      Backtrace
      • 14. app/Models/Journal.php:64
      • 15. app/Http/Controllers/ArticleController.php:2516
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=56) and sj.journal_id!=56 group by `j`.`nid`) as `aggregate_table`
      1.93msalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 16. app/Models/Subject.php:200
      • 17. app/Http/Controllers/ArticleController.php:2517
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=56) and sj.journal_id!=56 group by `j`.`nid` order by `j`.`journal_id` asc limit 10 offset 0
      950μsalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 14. app/Models/Subject.php:200
      • 15. app/Http/Controllers/ArticleController.php:2517
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=56) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid`) as `aggregate_table`
      1.97msalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 16. app/Models/Subject.php:220
      • 17. app/Http/Controllers/ArticleController.php:2518
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=56) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid` order by `v`.`ebook_volume_id` desc limit 10 offset 0
      1.85msalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 14. app/Models/Subject.php:220
      • 15. app/Http/Controllers/ArticleController.php:2518
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `keywords` where `article_id` = '122615'
      380μsalphaeurekaselec_live_10_06_2022Keywords.php#43
      Bindings
      • 0: 122615
      Backtrace
      • 13. app/Models/Keywords.php:43
      • 14. app/Http/Controllers/ArticleController.php:2519
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `article_citation` where `article_id` = '122615'
      4.88msalphaeurekaselec_live_10_06_2022Article.php#1570
      Bindings
      • 0: 122615
      Backtrace
      • 13. app/Models/Article.php:1570
      • 14. app/Http/Controllers/ArticleController.php:2520
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select CONCAT_WS(' ',au.first_name, ' ', ifnull(au.initials,''), ' ', au.last_name) as authors, CONCAT(au.last_name, IFNULL(CONCAT(' ', au.initials), ''), ' ', au.first_name) AS authorsRIS, CONCAT_WS(' ',au.last_name, ' ', ifnull(au.initials,''), ' ', au.first_name) as authorsCiteAs, CONCAT_WS(' ',au.first_name, IFNULL(CONCAT(' ', au.initials), ''), IFNULL(CONCAT(' ', au.last_name), '')) as authorsmodal , `au`.*, `af`.`ror_id`, `af`.`institution`, `af`.`department`, `af`.`country`, `af`.`city`, `af`.`address`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.institution,','),''), ifnull(concat(af.department,','),''), ifnull(concat(af.address,','),''), ifnull(concat(af.city,','),''), ifnull(concat(af.country,','),''), ifnull(concat(af.postal_code,','),''), ifnull(concat(af.phone,','),''), ifnull(concat(af.fax,','),''))) SEPARATOR '|')) as `author_affiliation`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.web_view,','),''))) SEPARATOR '|')) as `web_view` from `author` as `au` left join `author_affiliation` as `af` on `au`.`author_id` = `af`.`author_id` where `au`.`article_id` = '122615' group by `au`.`author_id` order by `au`.`article_id` asc, `au`.`sequence` asc
      3.82msalphaeurekaselec_live_10_06_2022Author.php#86
      Bindings
      • 0: 122615
      Backtrace
      • 13. app/Models/Author.php:86
      • 14. app/Http/Controllers/ArticleController.php:2533
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      350μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2535
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `subtitle` from `journal` where `continues_publication_journal` = 1
      700μsalphaeurekaselec_live_10_06_2022Article.php#1960
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/Article.php:1960
      • 14. app/Http/Controllers/ArticleController.php:2062
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • Select j.subtitle, v.volume_id as volume_id,v.year_id,y.year as year,v.volume_name, v.total_no_of_issues, i.issue_id as issue_id,i.title as issue, i.publication_date as issue_pub_date from journal j join volume v on j.journal_id = v.journal_id join issue i on v.volume_id = i.volume_id join article a on a.issue_id = i.issue_id join year y on v.year_id = y.id where j.journal_id = 56 and i.is_uploaded = 1 order by v.volume_name+0 desc, i.title+0 desc limit 1
      47.61msalphaeurekaselec_live_10_06_2022Issue.php#298
      Backtrace
      • 11. app/Models/Issue.php:298
      • 12. app/Http/Controllers/ArticleController.php:2068
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 1 and a.journal_id = 56 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      14.11msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2070
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 4 and a.journal_id = 56 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      15.42msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2071
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select pdf, html, epub, prc from `article_metrics` where `article_id` = 122615 limit 1
      320μsalphaeurekaselec_live_10_06_2022Article.php#744
      Bindings
      • 0: 122615
      Backtrace
      • 14. app/Models/Article.php:744
      • 15. app/Http/Controllers/ArticleController.php:2091
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from content_by_diseases where content_id = 122615 and content_type = 'article' order by status desc limit 1
      370μsalphaeurekaselec_live_10_06_2022Article.php#751
      Backtrace
      • 11. app/Models/Article.php:751
      • 12. app/Http/Controllers/ArticleController.php:2094
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `node_meta` where `nid` = 203682 limit 1
      280μsalphaeurekaselec_live_10_06_2022Meta.php#30
      Bindings
      • 0: 203682
      Backtrace
      • 14. app/Models/Meta.php:30
      • 15. app/Http/Controllers/ArticleController.php:2101
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      320μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2108
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `tbl_ht_submission` as `h` where `h`.`subtitle` = 'MRMC' and (h.proposal_closing_date = 0 OR TO_DAYS(FROM_UNIXTIME(h.proposal_closing_date)) >= TO_DAYS(NOW())) order by `h`.`manuscript` asc
      430μsalphaeurekaselec_live_10_06_2022Article.php#2025
      Bindings
      • 0: MRMC
      Backtrace
      • 13. app/Models/Article.php:2025
      • 14. app/Http/Controllers/ArticleController.php:2112
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '122615' and content_type = 'a' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      540μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2186
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `first_page` < '497' and is_uploaded = 1 and issue_id = 12193 order by cast(first_page as SIGNED) desc limit 1
      670μsalphaeurekaselec_live_10_06_2022Article.php#1819
      Bindings
      • 0: 497
      Backtrace
      • 14. app/Models/Article.php:1819
      • 15. app/Http/Controllers/ArticleController.php:2470
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `last_page` > '512' and is_uploaded = 1 and issue_id = 12193 order by cast(first_page as SIGNED) asc limit 1
      570μsalphaeurekaselec_live_10_06_2022Article.php#1831
      Bindings
      • 0: 512
      Backtrace
      • 14. app/Models/Article.php:1831
      • 15. app/Http/Controllers/ArticleController.php:2472
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `language_id` from `multilanguage` where `short_code` = 'en'
      210μsalphaeurekaselec_live_10_06_2022ArticleController.php#2497
      Bindings
      • 0: en
      Backtrace
      • 14. app/Http/Controllers/ArticleController.php:2497
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select `source_lang_label`, `target_lang_label` from `multilanguage_labels` where `target_lang_id` = 1
      310μsalphaeurekaselec_live_10_06_2022MultiLanguage.php#23
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/MultiLanguage.php:23
      • 14. app/Http/Controllers/ArticleController.php:2498
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `id` from `multilanguage_article` where `article_id` = 122615 limit 1
      3.29msalphaeurekaselec_live_10_06_2022ArticleController.php#2506
      Bindings
      • 0: 122615
      Backtrace
      • 16. app/Http/Controllers/ArticleController.php:2506
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 20. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select b.banner_link, b.banner_name, b.banner_script, b.banner_remarks, b.banner_file_name, b.banner_placement, bd.content_type, bd.content_id from `tbl_banner` as `b` inner join `tbl_banner_detail` as `bd` on `bd`.`banner_id` = `b`.`banner_id` inner join `users` as `u` on `u`.`id` = `b`.`updated_by` inner join `journal` as `j` on `j`.`journal_id` = `bd`.`content_id` where `b`.`banner_journal` = 1 and `bd`.`content_type` = 'J' and `bd`.`content_id` = 56 and `b`.`banner_from_date` <= 1740497441 and `b`.`banner_to_date` >= 1740497441 and `b`.`banner_status` = 'A' order by `b`.`banner_id` desc
      1.61msalphaeurekaselec_live_10_06_2022Banner.php#95
      Bindings
      • 0: 1
      • 1: J
      • 2: 56
      • 3: 1740497441
      • 4: 1740497441
      • 5: A
      Backtrace
      • 13. app/Models/Banner.php:95
      • 14. app/Http/helpers.php:404
      • 17. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 18. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    • select b.banner_link, b.banner_name, b.banner_script, b.banner_remarks, b.banner_file_name, b.banner_placement, bd.content_type, bd.content_id from `tbl_banner` as `b` inner join `tbl_banner_detail` as `bd` on `bd`.`banner_id` = `b`.`banner_id` inner join `users` as `u` on `u`.`id` = `b`.`updated_by` inner join `journal` as `j` on `j`.`journal_id` = `bd`.`content_id` where `b`.`banner_journal` = 1 and `bd`.`content_type` = 'J' and `bd`.`content_id` = 56 and `b`.`banner_from_date` <= 1740497441 and `b`.`banner_to_date` >= 1740497441 and `b`.`banner_status` = 'A' order by `b`.`banner_id` desc
      1.44msalphaeurekaselec_live_10_06_2022Banner.php#95
      Bindings
      • 0: 1
      • 1: J
      • 2: 56
      • 3: 1740497441
      • 4: 1740497441
      • 5: A
      Backtrace
      • 13. app/Models/Banner.php:95
      • 14. app/Http/helpers.php:404
      • 17. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 18. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    • select count(*) as aggregate from `uc_cart_products` where cart_id='d6f20f411e195cdb4e18ec269274ef2c'
      280μsalphaeurekaselec_live_10_06_2022Cart.php#271
      Backtrace
      • 15. app/Models/Cart.php:271
      • 16. view::layouts._header:260
      • 18. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 20. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    App\Models\MultiLanguage
    1MultiLanguage.php#?
        _token
        CclvfyRytTAt4rlVcOYOqJOKWjlTLOh1p5Hp6GPQ
        uc_cart_id
        d6f20f411e195cdb4e18ec269274ef2c
        _previous
        array:1 [ "url" => "http://alpha.eurekaselect.com/article/122615" ]
        _flash
        array:2 [ "old" => [] "new" => [] ]
        PHPDEBUGBAR_STACK_DATA
        []
        path_info
        /article/122615
        status_code
        200
        
        status_text
        OK
        format
        html
        content_type
        text/html; charset=UTF-8
        request_query
        []
        
        request_request
        []
        
        request_headers
        0 of 0
        array:9 [ "cookie" => array:1 [ 0 => "wayfindertarget=eyJpdiI6Ink1a0ZJVlRMam1sNnB4dlJlRXA3ZEE9PSIsInZhbHVlIjoiQVZIcE1lVUI3T1UvdG10U051VThoMVhVRFUzSXlqUjBUWVVnZS8rRk45TT0iLCJtYWMiOiJlNmUwMmQzMGYzMjQ3ZGIzNjEzYzgwM2VjY2MyZmMyMTc2ZjAyYTRmYjVkMjE5YzU4NzVmNmZlNjg2NzUzNDMwIiwidGFnIjoiIn0%3Dwayfindertarget=eyJpdiI6Ink1a0ZJVlRMam1sNnB4dlJlRXA3ZEE9PSIsInZhbHVlIjoiQVZIcE1lVUI3T1UvdG10U051VThoMVhVRFUzSXlqUjBUWVVnZS8rRk45TT0iLCJtYWMiOiJlNmUwMmQzMGYzMjQ3" ] "accept-encoding" => array:1 [ 0 => "gzip, deflate" ] "accept" => array:1 [ 0 => "text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7" ] "user-agent" => array:1 [ 0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)" ] "upgrade-insecure-requests" => array:1 [ 0 => "1" ] "cache-control" => array:1 [ 0 => "no-cache" ] "pragma" => array:1 [ 0 => "no-cache" ] "connection" => array:1 [ 0 => "keep-alive" ] "host" => array:1 [ 0 => "alpha.eurekaselect.com" ] ]
        request_cookies
        0 of 0
        array:1 [ "wayfindertarget" => null ]
        response_headers
        0 of 0
        array:5 [ "content-type" => array:1 [ 0 => "text/html; charset=UTF-8" ] "cache-control" => array:1 [ 0 => "no-cache, private" ] "date" => array:1 [ 0 => "Tue, 25 Feb 2025 15:30:41 GMT" ] "set-cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6ImpBc0p6MFhTSU0ya1dESGl5V1d5WlE9PSIsInZhbHVlIjoiV3N0WHFoZFgvQWdoSWEvOVdHSEtyT1A5RzhLdmN5YSt1b0JqbHZKRGxvY2tmc0hHUjVXeS81YkVZYy9kYk96ejdUUjZDTWladE5PUmE5V0FtaDZXdXMzSVQ5dWRMSGtJSzgraldEN0VUZDltYUFLb25HZVVHejgvZUtubkRSYmciLCJtYWMiOiIwYzliYjI5ZDA2MmNjNDJlMjEzNzIyNzY0NjkxY2I4ZmMxZDk3YjYwOWRiNDkzYjIwNWE3M2IzNTgwMGYwODE3IiwidGFnIjoiIn0%3D; expires=Fri, 28 Feb 2025 03:30:41 GMT; Max-Age=216000; path=/; secure; samesite=laxXSRF-TOKEN=eyJpdiI6ImpBc0p6MFhTSU0ya1dESGl5V1d5WlE9PSIsInZhbHVlIjoiV3N0WHFoZFgvQWdoSWEvOVdHSEtyT1A5RzhLdmN5YSt1b0JqbHZKRGxvY2tmc0hHUjVXeS81YkVZYy9kYk96ejdUUjZDT" 1 => "alphaeurekaselectnet_session=eyJpdiI6IjVydXgzNlp5Zkl4YVNnbExOM1VoRUE9PSIsInZhbHVlIjoiemprMTBQbCtKa0FZM3VyQUNZOVdsT3pEaW4zS01nMlFDbTJvalhCQ2R6eVd2bDFVajFYS0NuaG1lZ1BqT0ZtcGJSdGhQaGpMLzhDVS94M2ZkUjRNcVNlR3JSc0xSdzZIQ1R2aHIrZElSUjViajBzTnBPMWp5Q2ltcU9xbkNpNk4iLCJtYWMiOiI3ZWI0NjE1MzE2Y2FlYzdhNmFhODJkNjlkYzY0MzgyNWVjZjAzYjE4ZGI1ZDRlZmY4NTc3ZTQ3NmYwNWM2YzVkIiwidGFnIjoiIn0%3D; path=/; secure; httponly; samesite=laxalphaeurekaselectnet_session=eyJpdiI6IjVydXgzNlp5Zkl4YVNnbExOM1VoRUE9PSIsInZhbHVlIjoiemprMTBQbCtKa0FZM3VyQUNZOVdsT3pEaW4zS01nMlFDbTJvalhCQ2R6eVd2bDFVajFYS0NuaG1" ] "Set-Cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6ImpBc0p6MFhTSU0ya1dESGl5V1d5WlE9PSIsInZhbHVlIjoiV3N0WHFoZFgvQWdoSWEvOVdHSEtyT1A5RzhLdmN5YSt1b0JqbHZKRGxvY2tmc0hHUjVXeS81YkVZYy9kYk96ejdUUjZDTWladE5PUmE5V0FtaDZXdXMzSVQ5dWRMSGtJSzgraldEN0VUZDltYUFLb25HZVVHejgvZUtubkRSYmciLCJtYWMiOiIwYzliYjI5ZDA2MmNjNDJlMjEzNzIyNzY0NjkxY2I4ZmMxZDk3YjYwOWRiNDkzYjIwNWE3M2IzNTgwMGYwODE3IiwidGFnIjoiIn0%3D; expires=Fri, 28-Feb-2025 03:30:41 GMT; path=/; secureXSRF-TOKEN=eyJpdiI6ImpBc0p6MFhTSU0ya1dESGl5V1d5WlE9PSIsInZhbHVlIjoiV3N0WHFoZFgvQWdoSWEvOVdHSEtyT1A5RzhLdmN5YSt1b0JqbHZKRGxvY2tmc0hHUjVXeS81YkVZYy9kYk96ejdUUjZDT" 1 => "alphaeurekaselectnet_session=eyJpdiI6IjVydXgzNlp5Zkl4YVNnbExOM1VoRUE9PSIsInZhbHVlIjoiemprMTBQbCtKa0FZM3VyQUNZOVdsT3pEaW4zS01nMlFDbTJvalhCQ2R6eVd2bDFVajFYS0NuaG1lZ1BqT0ZtcGJSdGhQaGpMLzhDVS94M2ZkUjRNcVNlR3JSc0xSdzZIQ1R2aHIrZElSUjViajBzTnBPMWp5Q2ltcU9xbkNpNk4iLCJtYWMiOiI3ZWI0NjE1MzE2Y2FlYzdhNmFhODJkNjlkYzY0MzgyNWVjZjAzYjE4ZGI1ZDRlZmY4NTc3ZTQ3NmYwNWM2YzVkIiwidGFnIjoiIn0%3D; path=/; secure; httponlyalphaeurekaselectnet_session=eyJpdiI6IjVydXgzNlp5Zkl4YVNnbExOM1VoRUE9PSIsInZhbHVlIjoiemprMTBQbCtKa0FZM3VyQUNZOVdsT3pEaW4zS01nMlFDbTJvalhCQ2R6eVd2bDFVajFYS0NuaG1" ] ]
        session_attributes
        0 of 0
        array:5 [ "_token" => "CclvfyRytTAt4rlVcOYOqJOKWjlTLOh1p5Hp6GPQ" "uc_cart_id" => "d6f20f411e195cdb4e18ec269274ef2c" "_previous" => array:1 [ "url" => "http://alpha.eurekaselect.com/article/122615" ] "_flash" => array:2 [ "old" => [] "new" => [] ] "PHPDEBUGBAR_STACK_DATA" => [] ]
        ClearShow all
        Date ↕MethodURLData
        #12025-02-25 15:30:41GET/article/122615514311